Grantham, Mayo, Van Otterloo & Co (GMO)
AVNS icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Avanos Medical AVNS Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-19,590
Closed -$501K – 584
2023
Q2 		$501K Buy
19,590
+1,690
+9% +$44.5K ﹤0.01% 558
2023
Q1 		$532K Buy
17,900
+10,200
+132% +$296K ﹤0.01% 554
2022
Q4 		$208K Buy
+7,700
New +$188K ﹤0.01% 676
2018
Q2 		– Sell
-13,900
Closed -$641K – 555
2018
Q1 		$641K Hold
13,900
– – ﹤0.01% 440
2017
Q4 		$642K Buy
13,900
+7,400
+114% +$340K ﹤0.01% 432
2017
Q3 		$293K Buy
6,500
+500
+8% +$21.3K ﹤0.01% 482
2017
Q2 		$236K Buy
6,000
+300
+5% +$11.3K ﹤0.01% 519
2017
Q1 		$217K Buy
+5,700
New +$222K ﹤0.01% 533

Other funds holding AVNS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return